Adhesive Small Bowel Obstruction (ASBO): Role of CT Scan in Guiding Choice and Timing for Treatment Options
Executive Summary
Adhesive Small Bowel Obstruction (ASBO) represents the leading cause of intestinal obstruction, accounting for 70–80% of small bowel obstruction (SBO) cases. Primarily a consequence of postoperative adhesions (85–90% of cases), ASBO poses a significant clinical challenge due to the risk of strangulation and transmural necrosis. Computerized Tomography (CT) has emerged as the gold standard for guiding treatment, offering 70–95% accuracy in diagnosing adhesions and identifying critical complications such as ischemia and closed-loop obstructions. While nonoperative management (NOM) utilizing water-soluble contrast media (WSCM) is effective for simple ASBO, surgical intervention is mandatory for cases involving strangulation or peritonitis. Delaying surgery beyond 36 hours in ischemic cases increases mortality from 8% to 25%.
Etiology and Classification
Bowel obstruction, or "ileus," is defined as the arrest of intestinal content progression. ASBO is a mechanical obstruction of the small bowel originating from extramural or intramural adhesions.
Primary Classifications of ASBO
Pathophysiology
The progression of ASBO involves a sequence of physiological failures that can lead to systemic crisis:
Fluid and Gas Accumulation: Swallowed air (70–80% nitrogen) and fluid cause intraluminal pressure to rise, leading to bowel distention.
Motility Shifts: Initially, peristalsis increases to overcome the obstacle, followed by exhaustion and relaxation (decreased motility).
Bacterial Overgrowth: Stasis promotes a surge in gram-negative enteric and anaerobic organisms.
Translocation and Sepsis: Increased mucosal permeability allows bacteria and endotoxins to enter the mesenteric lymph nodes and systemic circulation.
Ischemia and Necrosis: Rising pressure eventually impairs venous drainage and arterial supply. This is most rapid in closed-loop obstructions, where trapped gas and fluid cannot escape, leading to rapid perforation and gangrene.
Clinical Diagnosis and Symptomatology
Clinical diagnosis is often challenging as symptoms may be non-specific.
Key Clinical Indicators
Constipation: Pathognomonic for complete SBO. Incomplete cases may still pass some gas or semisolid stools.
Abdominal Pain: Typically intermittent and crampy in early stages. Intense, persistent pain non-responsive to morphine indicates ischemia.
Vomiting: Precocious and biliary in proximal SBO; late and potentially fecaloid in distal SBO.
Physical Signs:
Palpation: Marked tenderness or a positive Blumberg sign indicates peritoneal suffering.
Auscultation: Early "tinks" or metallic borborygmi; late silence indicates ileus or peritonitis.
Laboratory Findings: Leukocytosis, increased PCR, hyperlactatemia, and elevated PCT are used to screen for inflammation, ischemia, and sepsis.
The Role of CT Scanning in Guidance
While plain radiographs are the traditional first step (48–80% sensitivity), CT is essential for determining etiology and surgical necessity. Because adhesive bands are rarely visible, the CT diagnosis of ASBO is often one of exclusion.
Radiological Signs of Simple ASBO
Bird Beak Sign: A fusiform tapering at the transition zone from dilated to collapsed bowel with no other identifiable cause.
Small Bowel Feces Sign: Particulate material admixed with air proximal to the obstruction. This suggests preserved fluid resorption and is often associated with successful nonoperative management.
Dilation: Small bowel loops greater than 2.5–3 cm.
String of Pearls Sign: Trapped air bubbles between folds at the top of a fluid-filled loop.
Radiological Signs of Strangulated/Complicated ASBO
Mural Changes: Circumferential mural thickening (>3 mm), target/halo sign (submucosal edema), or mural pneumatosis (indicative of ischemia).
Vascular/Fluid Signs: Whirl sign (torsion of mesenteric vessels), mesenteric congestion, and the presence of two or more fluid collections (highly specific for ischemia).
Contrast Enhancement Patterns: Reduced or absent mural enhancement is highly specific for ischemia; hyperenhancement indicates early vasodilation.
Necrosis/Perforation: Portomesenteric gas combined with pneumatosis indicates irreversible necrosis; free intraperitoneal gas indicates perforation.
Closed-Loop Obstruction Identifiers
Closed-loop ASBO carries a high risk of transmural necrosis regardless of initial symptoms. CT identifiers include:
C-shaped, U-shaped, or "coffee bean" configurations.
Radial configuration of vertically oriented bowel loops.
Convergence of mesenteric vessels to a single point.
Treatment and Management Strategies
The management of ASBO requires balancing the risk of bowel necrosis against the risk of creating new adhesions through surgery.
Nonoperative Management (NOM)
Candidates for NOM include those without signs of strangulation, peritonitis, or devascularized bowel on CT.
Protocol: Nasogastric (NG) tube intubation, IV fluids, and observation.
Water-Soluble Contrast Medium (WSCM): Gastrografin (50–150 mL) is both diagnostic and therapeutic. If the contrast reaches the colon within 24 hours, resolution is predicted.
Timeline: NOM can be maintained for 48–72 hours. If no resolution occurs within 72 hours, surgery is recommended.
Surgical Management
Emergent Surgery: Required for strangulated ASBO, peritonitis, or CT-confirmed devascularization.
Urgent Surgery: Recommended for non-strangulated patients with a high risk of NOM failure (e.g., complete obstruction, lack of small bowel feces sign, or anterior parietal adhesions).
Delayed Surgery: Indicated if NG tube drainage on Day 3 exceeds 500 mL.
Laparoscopy: Preferred for first episodes or suspected single-band adhesions. A low threshold for open conversion is maintained for extensive adhesions.
Prevention and Scoring
Recurrence of ASBO is a significant concern, particularly in patients under 40 years old or those with matted adhesions.
Adhesion Prevention: Agents such as hyaluronic acid-carboxycellulose (HA) membranes and icodextrin are utilized to reduce new adhesion formation.
Peritoneal Adhesion Index (PAI): A standardized scoring system (0–30) based on the macroscopic appearance and distribution of adhesions across nine abdominal regions and bowel-to-bowel contact. This index assists in uniform measurement and treatment evaluation across clinical centers.